Latest Breaking News On - Skye bioscience - Page 10 : comparemela.com

Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion

Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Skye bioscienceMike moyerPunit dhillonDavid wirtaExchange commissionSkye bioscience incBioscience treats first patientGlaucoma phaseEmulsion phaseSci advisorsRisk factors

Skye Bioscience to Present at BTIG Ophthalmology Day and OIS XIII Ophthalmology Innovation Summit

Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system to address diseases including glaucoma and metabolic conditions, will present an overview of its.

San diegoUnited statesSkye bioscienceMike moyerCalifornia newsfile corpSkye bioscience incOmni hotel san diegoExchange commissionAnnual ophthalmologyInnovation showcaseOmni hotel sanSci advisorsRisk factors

Skye Bioscience, Inc : Skye Bioscience to Present at BTIG Ophthalmology Day and OIS XIII Ophthalmology Innovation Summit

Skye Bioscience, Inc : Skye Bioscience to Present at BTIG Ophthalmology Day and OIS XIII Ophthalmology Innovation Summit
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesRheinland pfalzMike moyerSkye bioscienceOmni hotel san diegoCalifornia newsfile corpSkye bioscience incExchange commissionAnnual ophthalmologyInnovation showcaseOmni hotel sanSci advisorsRisk factors

Skye Bioscience Announces Positive Phase 1 Trial Results for SBI-100 Ophthalmic Emulsion, Its First-in-Class CB1 Agonist Being Developed for the Treatment of Glaucoma

Skye Bioscience Announces Positive Phase 1 Trial Results for SBI-100 Ophthalmic Emulsion, Its First-in-Class CB1 Agonist Being Developed for the Treatment of Glaucoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesPunit dhillonTu diepSkye bioscienceMike moyerExchange commissionDevelopment officerSkye bioscience incCalifornia newsfile corpInvestor dayPharmaceutical potentialTrial resultsChief developmentEmulsion trial phaseSci advisors

Skye Bioscience (SKYE) Announces Positive Phase 1 Trial Results for SBI-100

Skye Bioscience (SKYE) Announces Positive Phase 1 Trial Results for SBI-100
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tu diepPunit dhillonSkye bioscience incDevelopment officerSkye bioscienceInvestor dayPharmaceutical potentialTrial resultsChief developmentEmulsion trial phase